1. KD. Tripathi. Drugs Acting on Skin and Mucous Membranes. Essentials of medical pharmacology. Seventh edition. 2013. Page – 894.
2. Craig Burkhart, Dean Morrell and Lowell Goldsmith. Dermatological Pharmacology. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1810.
3. Gerald G. Briggs and Roger K. Freeman. A. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 93-94.
4. Galderma. Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on April 2011] [Accessed 4th December 2020] https://clinicaltrials.gov/ct2/show/NCT00598832
5. Suleyman Piskin and Erol Uzunali. A review of the use of adapalene for the treatment of acne vulgaris. NCBI; PMC US National Library of Medicine, National Institute of Health. August 2007. [Accessed 4th December 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374937/
6. Gladerma Laboratories. Electronic Medicines Compendium (EMC); [Revised on June 2020] [Accessed 4th December 2020] https://www.medicines.org.uk/emc/files/pil.921.pdf
7. Gladerma Laboratories. U.S. Food & Drug Administration. [Revised on January 2013] [Accessed 4th December 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022320s004lbl.pdf